Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06359873 Completed - Atrial Fibrillation Clinical Trials

Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension

Start date: May 1, 2022
Phase:
Study type: Observational

Based on the data of inpatients with hypertension and a cross-sectional study with a large sample size, this study aims to find the early warning value of the left anteroposterior atrial diameter for the possible occurrence of atrial fibrillation in patients with hypertension, and compare the advantages and disadvantages of the above two methods for the early warning of the risk of atrial fibrillation in patients with hypertension, so as to achieve the purpose of early identification of high-risk groups that may develop atrial fibrillation.

NCT ID: NCT06226727 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Start date: February 14, 2024
Phase: Phase 1
Study type: Interventional

The objective of this clinical study is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-1" and "BR1019-2" in healthy volunteers

NCT ID: NCT06212648 Completed - Hypertension Clinical Trials

Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension

SP-CAP-002
Start date: March 25, 2022
Phase: Phase 2
Study type: Interventional

This study purpose is to determine the appropriate combination drug dose by comparing safety and efficacy with placebo, candesartan, and amlodipine monotherapy after 8 weeks of administration of SPC1001 to patients with essential hypertension.

NCT ID: NCT06184269 Completed - Clinical trials for Essential Hypertension

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"

Start date: December 23, 2023
Phase: Phase 1
Study type: Interventional

The objective of this clinical study is to evaluate the pharmacokinetics and the safety after administration of "BR1017-1" and co-administration of "BR1017-1A" and "BR1017-1B" in healthy volunteers

NCT ID: NCT06121518 Completed - Clinical trials for Essential Hypertension

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

Start date: July 31, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients

NCT ID: NCT05993806 Completed - Clinical trials for Essential Hypertension

A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

Start date: June 2, 2023
Phase: Phase 1
Study type: Interventional

This is a randomized, open, single-dose, crossover-design, phase 1, singlecenter study to evaluate bioequivalence after administration of L04RD1 or administration of L04TD3 in healthy volunteers.

NCT ID: NCT05987436 Completed - Clinical trials for Essential Hypertension

Effect of Aerobic Exercise in Patients With Essential Hypertension

Start date: November 1, 2017
Phase:
Study type: Observational

The goal of this observational study is to evaluate the effects of a supervised aerobic exercise training program on weight loss, functional capacity, quality of life (QoL), and depression levels in patients with essential hypertension.

NCT ID: NCT05684666 Completed - Clinical trials for Essential Hypertension

Effect of Breathing and Muscle Relaxation Technique in Individual With Essential Hypertension

Start date: February 21, 2019
Phase: N/A
Study type: Interventional

Primary hypertension, also called essential hypertension, is a rise in blood pressure (BP) with no identifiable cause. The most prevalent form of hypertension is essential hypertension, which involves 95% of patients with hypertension.Progressive muscle relaxation (PMR) is learning to relax some groups of muscles while paying attention to the feelings connected with both the tense and relaxed states.It is generally established that regular slow (deep) breathing exercises enhance respiratory and cardiovascular function by enhancing parasympathetic tone and reducing sympathetic activity, thus reducing BP, heart rate, respiratory rate, and stress levels in hypertensive patients. This study aimed to investigate the combined effect of slow breathing and PMR technique on BP, heart rate, respiratory rate, and anxiety in patients diagnosed with essential hypertension.

NCT ID: NCT05661721 Completed - Clinical trials for Hypertension,Essential

Licorice and Home Blood Pressure

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

Out-of-office blood pressure is more strongly associated with cardiovascular risk than office blood pressure. Licorice is known to raise blood pressure, but no previous studies have measured the effects on home blood pressure. The aim of this study is to analyze the association between licorice intake and home blood pressure.

NCT ID: NCT05631990 Completed - Clinical trials for Hypertension, Essential

A Study to Evaluate the Efficacy and Safety of AD-209

Start date: April 5, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of AD-209